Skip to Content

Eventide Healthcare & Life Sciences A ETAHX

Analyst rating as of
Premium

Morningstar’s Analysis

Will ETAHX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Co-Portfolio Managers Added to Eventide Gilead and Healthcare & Life Sciences; No Ratings Changes

Senior Analyst

Analyst Note

| |

Eventide Asset Management announced that, effective Jan. 1, 2022, it is promoting Anant Goel to co-portfolio manager of Eventide Gilead ETGLX, Joy Ghosh to co-portfolio manager of Eventide Healthcare & Life Sciences ETNHX, and Andrew Singer to co-portfolio manager of Eventide Dividend Opportunities ETNDX. Goel and Ghosh join firm co-founder Finny Kuruvilla, who was previously the only named manager of Eventide Gilead and Healthcare & Life Sciences, while Singer joins Dolores Bamford, who has been the only named manager of the Dividend Opportunities fund since 2019.

Unlock our full analysis with Morningstar Premium